Saphyre Named FinTech of the Year by The TRADE at the Leaders in Trading New York Awards
HOBOKEN, N.J., Dec. 3, 2025 /PRNewswire/ — Saphyre, Inc., a leading pre-thru-post-trade platform for some of the world’s largest financial institutions,... Read more.
LeapXpert Partners with AVANT to Power the Next Generation of Governed Business Messaging
Rising demand for governed communication meets rapid go-to-market acceleration as LeapXpert joins AVANT’s ecosystem, bringing The LeapXpert Communications... Read more.
Medscape Education Earns EBAH Accreditation Status for Hematology CME Excellence
LONDON, Dec. 3, 2025 /PRNewswire/ — Medscape Education International, the leading digital platform for physicians and healthcare professionals, has received... Read more.
Crisil features in Chartis RiskTech100 2026 for third successive year
Improves ranking to #36; retains pole position in Model Validation category MUMBAI, India and NEW YORK and LONDON, Dec. 3, 2025 /PRNewswire/ — Crisil... Read more.
CData Study Finds Only 6% of AI Leaders Believe Their Data Infrastructure Is Ready for AI
More than 200 AI leaders reveal that data infrastructure maturity — not models — is the strongest predictor of AI success CHAPEL HILL, N.C., Dec. 3, 2025 /PRNewswire/... Read more.
Tampa General Hospital and Palantir Technologies Honored with Inno Award for Partnership of the Year by Tampa Bay Business Journal
Tampa General and Palantir were recognized for their ongoing collaboration to revolutionize care coordination and delivery at the region’s only academic health... Read more.
Magaya Unveils Momentum Magazine, a New Annual Publication Delivering Insights and Inspiration for Freight Forwarders and Customs Brokers
MIAMI, Dec. 3, 2025 /PRNewswire/ — Magaya Corporation, the leading freight management platform for logistics service providers, today announced the launch... Read more.
Virax Biolabs’ CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Virax Biolabs’ proprietary in-development diagnostic technology for post-acute infection syndromes (“PAIS”), such as Long COVID, positions the... Read more.
HilltopAds Introduces Dedicated iGaming Feature Suite and Managed Performance Service
LONDON, Dec. 3, 2025 /PRNewswire/ — HilltopAds announced the rollout of a specialized feature set built exclusively for iGaming advertisers, reinforcing the... Read more.
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated an 89.8% ORR and 77.6% CR across the 49 efficacy-evaluable patients with a minimum of 6 months... Read more.